Research

We discover personalized medical solutions for environmentally triggered diseases.

Understanding Metabolism from Beginning to End

Our metabolism is not a static system. It is shaped even before birth, adapts throughout life to nutrition and the environment,…

Translation: Where Medical Research Reaches People

How can we bring new scientific insights to patients more quickly? At Helmholtz Munich, we work hand in hand with leading…

Nurse and patient in hospital bed with medical monitors

How Foundation Models Are Shaping Biomedical Research

AI-powered foundation models like GPT have evolved from everyday tools for simple tasks to powerful systems capable of…

An AI powered system automating remote patient monitoring by analyzing real time health data and vital signs, futuristic AI-driven healthcare platform_AdobeStock_1366228679

Science Through an Artistic Lens

In a world where scientific innovation is increasingly interconnected, the RepliFate-Artist in Residence program seeks to…

Artist in Residence Programme_Cellular Reprogramming Necklace by Anna Dumitriu photo credit Audrey Rose Mizzi large_QUER

Tracing the First Building Blocks of Life

What connects Helmholtz Munich with space research? The globally unique analytical methods developed by Prof. Philippe…

Bennu polycam mosaic obtained before spacecraft arrival
December 10, 2018
This mosaic image of asteroid Bennu is composed of 12 PolyCam images collected on Dec. 2 by the OSIRIS-REx spacecraft from a range of 15 miles (24 kilometers). The image was obtained at a 50° phase angle between the spacecraft, asteroid and the Sun, and in it, Bennu spans approximately 1,500 pixels in the camera’s field of view.

Instrument Used: OCAMS (PolyCam)

Ali Ertürk’s Journey in Transformative Biomedical Imaging

Imagine a world where the most intricate networks and processes within whole bodies are visible – down to the level of…

Ferroptosis: Controlling Life or Death of Cells

Cell death is indispensable to life, as it ensures the removal of damaged or unnecessary cells. Among the many ways a cell can…

Timo Müller, Director of the Institute for Diabetes and Obesity (IDO) at Helmholtz Munich and Professor at Ludwig-Maximilians-Universität München (LMU), has received the 2026 Gill Transformative Investigator Award. With this distinction, the Gill…

v.l.n.r.
Prof. Dr. Annette Peters, Dr. Alexandra Schneider

Under the theme "Understanding and Responding to Global and Local Challenges in a Changing World," researchers at the 38th Annual Conference of the International Society for Environmental Epidemiology (ISEE) presented new work on how air pollution,…

World Diabetes Awareness: Blue Ribbon, Sugar Cubes, and Globe on Blue Background.

An international team of experts has issued specific recommendations for population-wide screening of children for type 1 diabetes. The consensus paper, published in the journal Diabetologia, sets out when children should be tested and how a…

Gruppenbild im Treppenhaus des Roten Hausesv. l. n. r.:
Michael Stumvoll, Michael Frieser, Cristina Petersen, Bilal Sheikh, Matthias Blüher, Babett Gläser, Antje Körner, Ulrike Poller, Sarah Frenzel, Theda Wessel, Gefion Liebau, Angela Dargel, Konstanze Julich-Gruner

How can research help prevent obesity before disease develops? This question was a key focus during the visit by representatives from the German Federal Ministry of Health (BMG) and the Saxon State Ministry for Science, Culture and Tourism (SMWK) to…

Daniel Kotlarz, group leader at the Institute of Translational Genomics at Helmholtz Munich and Heisenberg Professor of Precision Medicine of Pediatric Inflammatory Bowel Diseases at LMU University Hospital Munich receives around 600,000 Euros…

FEBS|EMBO Women in Science Prize for Eleftheria Zeggini

Prof. Eleftheria Zeggini has been awarded the FEBS | EMBO Women in Science Award 2027 for her pioneering contributions to human genomics and the translation of large-scale genetic discoveries into biological and clinical insights, alongside her…

Cell membranes and the proteins within them control many vital processes and play a key role in health and disease. But studying them in 3D images of cells has so far meant slow, manual work. A team from Helmholtz Munich, the Technical University of…

Dr. Reid Alderson from the Institute of Structural Biology and the Institute of Computational Biology at Helmholtz Munich has received a Starting Grant from the European Research Council (ERC). Through the Protein-DANCE project, he will develop a new…

Dr. Marcel Binz from the Institute for Human-Centered AI at Helmholtz Munich has received a Starting Grant from the European Research Council (ERC). Through the MIDAS project, he will develop large-scale computational models designed to simulate,…

Proteinbausteine mit synthetischen Proteinstrukturen als RNA-Transporter werden mithilfe generativer KI entworfen_Helles Bild

Researchers at Helmholtz Munich and the Technical University of Munich (TUM) have developed Synthetic Transfer Vehicles (STVs), an entirely new class of RNA transporters. To do so, they combined naturally occurring protein building blocks with…

Closeup timelapse of layered muscle fibers diminishing over time illustrating severe muscle atrophy in cancer cachexia.

Researchers at Helmholtz Munich, the Heidelberg Faculty of Medicine at Heidelberg University, the German Center for Diabetes Research (DZD) and the Technical University of Munich (TUM), have identified a previously unknown mechanism that can drive…

The CureGPX4 Foundation has named Prof. Marcus Conrad, Director of the Institute of Metabolism and Cell Death at Helmholtz Munich, as the first recipient of the Raghav Prize for Rare Disease and Citizen Science. The prize recognizes his research into…

The "farm effect" can protect against allergies, asthma, and hay fever.

An international research team has identified for the first time which bacteria in barn air are responsible for the "farm effect" that can protect against allergies, asthma, and hay fever.

A daily routine for children with type 1 diabetes: monitoring blood glucose.

Research fully realizes its value where it reaches people – when findings translate into new treatment options from which those affected can benefit. How this can be achieved in practice for type 1 diabetes is demonstrated by the Institute of…

Arzt mit Stethoskop und geöffneten Händen. Über den Händen schwebt eine schematische Grafik der Lunge. Daneben verschiedene Icons zu medizinischen Leistungen

Helmholtz Munich and Khumbu are collaborating on a new research program led by Prof. Ali Önder Yildirim, Director of the Institute of Lung Health and Immunity at Helmholtz Munich. The collaboration aims to develop a novel therapeutic approach for…

A new interdisciplinary team at Helmholtz Munich aims to bridge one of healthcare AI's longstanding challenges: translating promising algorithms into tools that perform reliably in clinical practice. The M1 Clinical AI Consultants, based at the…

Using advanced intravital microscopy, Helmholtz Munich researchers have been able to observe early immune reactions in the living lung in real time. The images show that specific T cells are activated within hours after contact with components of…

Dr. Robert Frömel and Dr. Hossam Montaser have been awarded Marie Skłodowska Curie Postdoctoral Fellowships. Over a period of two years, the EU funded fellowships will support their independent research projects on gene regulation in brain…

Cover of the Pixi book from Carlsen, which describes type 1 diabetes.

The new Pixi Wissen book, “Finn and the Sleepover – Type 1 Diabetes at School”, demonstrates how research can be translated into practical resources for everyday life. Together with partners, Helmholtz Munich has developed a scientifically grounded,…

A close-up visualization of the CRISPR Cas9 mechanism at work, showcasing the intricate molecular interactions involved in gene editing.

A research team led by Prof. Stefan Stricker at Helmholtz Munich and Ludwig Maximilian University has developed TAPIR, a CRISPR-based technology that enables precise control of protein production in cells. The method provides new insights into the…

Core facilities support and enable our center’s research by providing centralized access to cutting-edge technologies, instruments and highly skilled staff, fostering innovation and connecting scientists across disciplines.

Find out more

Artificial Intelligence in Healthcare - New AI Applications in Medicine

Our cutting-edge research forms the basis for medical innovations. Together with our partners, we are accelerating the transfer of our research to bring new ideas from the laboratories to application even faster.
n addition to implementing innovative diagnostics, medical technologies, sustainable prevention measures and personalized therapeutics, we are shaping a dialogical and interactive transfer of knowledge. In this way, we make a valuable contribution to a healthier society.

More information

Vascular and glomeruli details of the human kidney.

Eleftheria Zeggini

"We discover breakthrough solutions for better health in a rapidly changing world."

to Eleftheria's page

Prof. Dr. Eleftheria Zeggini

Program Director ENABLE

Stephan Herzig

"It is my vision to successfully drive a mechanistic finding into clinical application in the area of obesity-related metabolic dysfunction as well as cancer cachexia."

to Stephan's page

Prof. Dr. Stephan Herzig

Director of the Diabetes Center, Scientific Director

Martin Hrabě de Angelis

"Leading science means guiding discovery toward public good – with excellence, integrity, and impact."

to Martin's page

Porträt Martin Hrabe de Angelis
Querformat
Background: Office / Indoorplant

Prof. Dr. Dr. h.c. Martin Hrabě de Angelis

Member and Spokesperson of the Executive Board (acting), Director of the Institute of Experimental Genetics, Scientific Director

Fabian Theis

"With AI we can imagine a future where diagnosing and treating diseases is more affordable, widely available, and thus more democratic."

to Fabian's page

Prof. Dr. Fabian Theis

Director of the Computational Health Center

Vasilis Ntziachristos

"Our research at Helmholtz Munich is driven by our interest to provide solutions that address critical unmet medical need and positively impact healthcare and the well-being of society."

Prof. Dr. Vasilis Ntziachristos

Director of the Bioengineering Center

Erika von Mutius

"I am a passionate pediatrician scientist. My research focusses on the roots of asthma and allergy development with the aim of ultimately preventing these diseases in children at risk."

freigestelltes Porträtbild für Kontakte auf der Website

Prof. Dr. Erika von Mutius

Director of the Environmental Health Center

Magdalena Götz

"My vision is to explore the mechanisms of neurogenesis to use it for instructing neurogenesis for replacement of lost neurons."

Prof. Dr. Magdalena Götz

Director of the Stem Cell Center

Michael Sattler

"We combine integrative structural biology to elucidate molecular mechanisms of biological pathways, highlighting the essential roles of dynamics and transient regulatory interations to enable innovative structure-based drug discovery."

to Michael´s page

Prof. Dr. Michael Sattler

Director of the Molecular Targets & Therapeutics Center

We collaborate with a dynamic network of regional and international partners. Together, we engage in impactful projects and cooperations that shape the future of medicine.
Read more

Blue and white sphere network structure - abstract design connection design - 3D illustration

On This Page

Understanding Metabolism from Beginning to End

Translation: Where Medical Research Reaches People

How Foundation Models Are Shaping Biomedical Research

Science Through an Artistic Lens

Tracing the First Building Blocks of Life

Ali Ertürk’s Journey in Transformative Biomedical Imaging

Ferroptosis: Controlling Life or Death of Cells

Timo Müller Receives 2026 Gill Transformative Investigator Award

ISEE 2026 in Munich Presents New Research on Environmental Health

Experts Recommend Systematic Screening of Children for Type 1 Diabetes

How Clinical Research at HI-MAG Is Shaping the Future of Obesity Prevention

Funding to Advance Precision Medicine for Inflammatory Bowel Disease in Children

Eleftheria Zeggini Receives FEBS | EMBO Women in Science Award 2027

Weeks of Work in a Few Hours: AI Tool Reads Cell Membranes

Reid Alderson Receives ERC Starting Grant for Protein-DANCE

Marcel Binz Receives ERC Starting Grant for MIDAS

AI-Designed Proteins Enable a New Generation of RNA Transporters

Cancer Cachexia: How a Tumor Protein Drives Wasting in the Body

Marcus Conrad Receives Inaugural Raghav Prize for Rare Disease Research

Immune System: The Farm Effect – Clearer Than Ever

From the Lab to the Patient: Four Clinical Trials on Type 1 Diabetes

Helmholtz Munich and Khumbu Start Joint Program on COPD

Helmholtz Munich Launches M1 Clinical AI Consultants to Bring AI Research to Patient Care

SARS-CoV-2: Real-time Imaging Reveals Unexpectedly Fast Immune Response in the Lung

Two MSCA Postdoctoral Fellowships Awarded to Researchers at Helmholtz Munich

Pixi Wissen Book: Type 1 Diabetes at School

New CRISPR Method Makes It Possible to Control Protein Production in Cells